Phraxis presented at the 8th Annual Meeting of the American Society of Diagnostic and Interventional Nephrology (ASDIN) Annual Scientific Meeting, February 24 –26, 2012, New Orleans, LA.
For more details: Click Here
For more details: Click Here
Phraxis, Inc.
Your Subtitle text
Phraxis Home
Phraxis, Inc. is an early stage medical device company founded to develop novel treatment solutions for patients who need vascular access to enable hemodialysis. Phraxis, Inc.’s first product for commercialization, the InterGraft, will be a percutaneously delivered arterio-venous shunt that provides a unique, non-surgical approach for patients who need vascular access.
